CGRP measurements in human plasma – a methodological study
Autor: | Annette Kuhn, Florian Frank, Julika Sertel-Nakajima, Karl Messlinger, Birgit Vogler, Gregor Broessner |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Calcitonin Gene-Related Peptide Enzyme-Linked Immunosorbent Assay Peptide normobaric hypoxia Pharmacology Calcitonin gene-related peptide Plasma 03 medical and health sciences 0302 clinical medicine Primary headache Blood plasma Humans Medicine ddc:610 chemistry.chemical_classification business.industry Original Articles General Medicine Plasma levels 030104 developmental biology chemistry Human plasma Biomarker (medicine) Methodological study Neurology (clinical) business Biomarkers 030217 neurology & neurosurgery blood plasma |
Zdroj: | Cephalalgia |
ISSN: | 1468-2982 0333-1024 |
Popis: | Background Calcitonin gene-related peptide plasma levels have frequently been determined as a biomarker for primary headaches. However, published data is often inconsistent resulting from different methods that are not precisely described in most studies. Methods We applied a well-proven enzyme-linked immunosorbent assay to measure calcitonin gene-related peptide concentrations in human blood plasma, we modified parameters of plasma preparation and protein purification and used calcitonin gene-related peptide-free plasma for standard solutions, which are described in detail. Results Calcitonin gene-related peptide levels are stable in plasma with peptidase inhibitors and after deep-freezing. Calcitonin gene-related peptide standard solutions based on synthetic intercellular fluid or pooled plasma with pre-absorbed calcitonin gene-related peptide influenced the measurements but yielded both comprehensible results. In a sample of 56 healthy subjects the calcitonin gene-related peptide plasma levels varied considerably from low (500 pg/mL) values. After a 12-hour exposure of these subjects to normobaric hypoxia the individual calcitonin gene-related peptide levels remained stable. Conclusion Buffering with peptidase inhibitors and immediate freezing or processing of plasma samples is essential to achieve reliable measurements. Individuals show considerable differences and partly high calcitonin gene-related peptide plasma levels without detectable pathological reason. Thus plasma measurements are suited particularly to follow calcitonin gene-related peptide levels in longitudinal studies. The use of data for this study was approved by the Ethics Committee of the Medical University of Innsbruck ( https://www.i-med.ac.at/ethikkommission/ ; EK Nr: 1242/2017). |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |